Skip to content

An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes

An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes - An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008369
Enrollment
40
Registered
2012-07-06
Start date
2010-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

insulin aspart three times daily insulin detemir at bedtime

Sponsors

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Type 2 diabetes 2)HbA1c >=7.4%

Exclusion criteria

Exclusion criteria: 1)Patients with allergies to insulin aspart or detemir 2)None type 2 diabetes 3)Medical history and/or complication of diabetic ketoacidosis 4)Medical history and/or complication of severe hypoglycemia 5)Treatment with insulin, DPP-4 inhibitor or GLP-1 analogue within 4 weeks prior to the study 6)Treatment with glucocorticoid 7)Uncontrolled hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 8)Patients with proliferative retinopathy or maculopathy 9)Medical history and/or malignancy 10)Severe complications and problems not suitable for the study 11)Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
M values

Countries

Japan

Contacts

Public ContactYUMIE Takeshita

Kanazawa University Graduate School of Medical Sciences Department of Disease Control and Homeostasis

takeshita@m-kanazawa.jp076-265-2234

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026